NasdaqCM - Nasdaq Real Time Price USD

STRATA Skin Sciences, Inc. (SSKN)

Compare
3.1000 +0.0100 (+0.32%)
As of 10:31 AM EST. Market Open.
Loading Chart for SSKN
DELL
  • Previous Close 3.0900
  • Open 3.0500
  • Bid --
  • Ask --
  • Day's Range 2.9404 - 3.1700
  • 52 Week Range 2.5100 - 7.0000
  • Volume 79,177
  • Avg. Volume 10,859
  • Market Cap (intraday) 12.931M
  • Beta (5Y Monthly) 1.32
  • PE Ratio (TTM) --
  • EPS (TTM) -2.3700
  • Earnings Date Nov 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 16.00

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

www.strataskinsciences.com

99

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SSKN

View More

Performance Overview: SSKN

Trailing total returns as of 11/11/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SSKN
43.64%
S&P 500
25.76%

1-Year Return

SSKN
6.06%
S&P 500
35.86%

3-Year Return

SSKN
82.68%
S&P 500
29.09%

5-Year Return

SSKN
88.64%
S&P 500
93.93%

Compare To: SSKN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SSKN

View More

Valuation Measures

Annual
As of 11/8/2024
  • Market Cap

    12.90M

  • Enterprise Value

    23.92M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.33

  • Price/Book (mrq)

    1.36

  • Enterprise Value/Revenue

    0.73

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -25.40%

  • Return on Assets (ttm)

    -6.79%

  • Return on Equity (ttm)

    -62.97%

  • Revenue (ttm)

    32.73M

  • Net Income Avi to Common (ttm)

    -8.31M

  • Diluted EPS (ttm)

    -2.3700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.48M

  • Total Debt/Equity (mrq)

    173.86%

  • Levered Free Cash Flow (ttm)

    1.44M

Research Analysis: SSKN

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 8.44M
Earnings -99k
Q3'23
Q4'23
Q1'24
Q2'24
-2M
0
2M
4M
6M
8M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

16.00
16.00 Average
3.1000 Current
16.00 High
 

Company Insights: SSKN

People Also Watch